Steven Cohen's LXEO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.89 M shares of Lexeo Therapeutics, Inc. (LXEO) worth $18.81 M, representing 0.02% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 6 quarters.
Based on 13F filings, Steven Cohen has maintained this position in LXEO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 1.29 M shares. Largest reduction occurred in Q2 2025, reducing 450,263 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Lexeo Therapeutics (LXEO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Lexeo Therapeutics (LXEO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -47,127 | Reduce 2.43% | 1.89 M | $9.93 |
| Q3 2025 | +1.29 M | Add 199.72% | 1.94 M | $6.64 |
| Q2 2025 | -450,263 | Reduce 41.00% | 647,880 | $4.02 |
| Q1 2025 | +347,908 | Add 46.37% | 1.1 M | $3.47 |
| Q4 2024 | +379,828 | Add 102.54% | 750,235 | $6.58 |
| Q3 2024 | +370,407 | New Buy | 370,407 | $9.04 |
Steven Cohen's Lexeo Therapeutics Investment FAQs
Steven Cohen first purchased Lexeo Therapeutics, Inc. (LXEO) in Q3 2024, acquiring 370,407 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Lexeo Therapeutics, Inc. (LXEO) for 6 quarters since Q3 2024.
Steven Cohen's largest addition to Lexeo Therapeutics, Inc. (LXEO) was in Q3 2025, adding 1,941,849 shares worth $12.89 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,894,722 shares of Lexeo Therapeutics, Inc. (LXEO), valued at approximately $18.81 M.
As of the Q4 2025 filing, Lexeo Therapeutics, Inc. (LXEO) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Lexeo Therapeutics, Inc. (LXEO) was 1,941,849 shares, as reported at the end of Q3 2025.